In a welcome move, Cardinal Health stock saw its Relative Strength Rating improve from 63 to 71 on Wednesday.
This exclusive rating from Investor's Business Daily measures price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains typically have an 80 or higher RS Rating as they begin their biggest price moves. See if Cardinal Health stock can continue to rebound and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Is Cardinal Health Stock A Buy?
Cardinal Health stock is working on a cup with handle with a 110.82 buy point. See if it can break out in volume at least 40% higher than normal. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
Earnings grew 29% last quarter, up from 14% in the prior report. Revenue also increased, from 9% to 12%.
Cardinal Health stock holds the No. 3 rank among its peers in the Medical-Wholesale Drugs industry group. PetIQ Cl A is the top-ranked stock within the group.
